家禽診斷市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

2023 年，全球家禽診斷市場價值為 7.025 億美元，預計 2024 年至 2032 年複合年成長率為 10.5%。這些工具利用分子診斷和血清學測試等技術，幫助識別病原體並監測雞群健康狀況，解決禽流感和沙門氏菌病等疾病。有效的診斷對於疾病控制、生物安全和家禽養殖的經濟穩定發揮著至關重要的作用。這一市場成長的主要驅動力是人們日益認知到家禽疾病對食品安全和公共衛生的影響。

全球更嚴格的法規旨在提高家禽健康標準，從而擴大使用診斷工具進行早期疾病識別和預防。這些工具對於早期檢測禽流感、新城疫和沙門氏菌等疾病至關重要，以便及時採取干涉措施，以防止疫情爆發。市場分為組成部分，主要是產品和服務。該產品細分市場到2023年佔60.4%的市場佔有率，進一步分為試劑盒和試劑以及設備和儀器。

診斷試劑盒和試劑等產品因其成本效益和可及性而廣受歡迎，使農民能夠透過最少的培訓來監測雞群健康狀況。快速檢測試劑盒可快速提供結果，特別有益，使農民能夠即時管理雞群健康並防止疾病升級。就技術而言，市場分為PCR檢測、ELISA檢測等。 ELISA 檢測在檢測多種家禽病原體方面具有高靈敏度和特異性，到 2023 年價值將達到 4.032 億美元，在該領域佔據主導地位。

ELISA 的快速結果和最新的技術進步使其成為尋求可靠診斷的家禽生產商的首選。從疾病角度來看，市場包括禽流感、新城疫、禽沙門氏菌病等。禽流感部分預計在預測期內將以 10.8% 的速度成長。由於其傳染性以及對家禽和人群的影響，禽流感的早期檢測和控制變得至關重要，從而推動了診斷投資。

家禽診斷的最終用戶包括獸醫院和診所、家禽養殖場和診斷實驗室。 2023年，由於家禽疾病的日益普及以及對確保準確疾病檢測的專業診斷服務的需求，獸醫院和診所的價值達到3.238億美元。在美國，家禽診斷市場 2023 年價值 2.578 億美元，預計到 2032 年將達到 6.168 億美元

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 增加家禽消費
    • 家禽健康意識不斷增強
    • 人畜共患病發生率上升
  • 產業陷阱與挑戰
    • 發展中地區獲得先進技術的機會有限
• 成長潛力分析
• 監管環境
• 未來市場趨勢
• 定價分析
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按組成部分，2021 - 2032 年

• 主要趨勢
• 產品
  • 試劑盒和試劑
  • 設備儀器
• 服務
  • 臨床化學
  • 分子診斷
  • 血清學
  • 細菌學
  • 病毒學
  • 寄生蟲學
  • 其他服務

第 6 章：市場估計與預測：按技術分類，2021 - 2032 年

• 主要趨勢
• 酵素連結免疫吸附試驗
• PCR檢測
• 其他技術

第 7 章：市場估計與預測：按疾病類型，2021 - 2032

• 主要趨勢
• 禽流感
• 禽沙門氏菌病
• 新城疫
• 禽支原體疾病
• 傳染性支氣管炎
• 傳染性法氏囊病
• 禽巴氏桿菌病
• 禽腦脊髓炎
• 禽呼腸孤病毒
• 雞貧血
• 其他疾病

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 獸醫醫院和診所
• 家禽養殖場
• 診斷實驗室

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：公司簡介

• Affinitech
• Agrobiotek Internacional
• Agrolabo
• Antech Diagnostics
• BIOMERIEUX
• Boehringer Ingelheim
• Embark Veterinary
• FUJIFILM Corporation
• GD Animal Health
• IDEXX Laboratories
• IDvet
• Innovative Diagnostics
• Megacor Diagnostik
• Thermo Fisher Scientific
• Zoetis

The Global Poultry Diagnostics Market, valued at USD 702.5 million in 2023, is anticipated to grow at a CAGR of 10.5% from 2024 to 2032. Poultry diagnostics are essential tools and methods used to detect and manage diseases in birds raised for meat and eggs. Utilizing techniques like molecular diagnostics and serological tests, these tools help identify pathogens and monitor flock health, addressing diseases such as avian influenza and salmonellosis. Effective diagnostics play a crucial role in disease control, biosecurity, and the economic stability of poultry farming. A primary driver of this market growth is the increasing awareness of the impact of poultry diseases on food safety and public health.

Stricter regulations worldwide aim to enhance poultry health standards, resulting in the expanded use of diagnostic tools for early disease identification and prevention. Such tools are vital for detecting diseases like avian influenza, Newcastle disease, and Salmonella at early stages, allowing timely interventions to prevent outbreaks. The market is divided into components, primarily products and services. The product segment, which held a 60.4% market share in 2023, is further categorized into kits & reagents and equipment & instruments.

Products such as diagnostic kits and reagents are popular for their cost-effectiveness and accessibility, allowing farmers to monitor flock health with minimal training. Rapid test kits, providing quick results, are particularly beneficial, enabling farmers to manage flock health in real-time and prevent disease escalation. In terms of technology, the market is segmented into PCR tests, ELISA tests, and others. ELISA tests, valued at USD 403.2 million in 2023, dominate the segment due to their high sensitivity and specificity in detecting a wide array of poultry pathogens.

ELISA's rapid results and recent technological advancements make it a preferred option among poultry producers seeking reliable diagnostics. Disease-wise, the market includes avian influenza, Newcastle disease, avian salmonellosis, and others. The avian influenza segment is projected to grow at a rate of 10.8% over the forecast period. Due to its contagious nature and impact on both poultry and human populations, early detection and control of avian influenza have become critical, driving investment in diagnostics.

End users of poultry diagnostics include veterinary hospitals & clinics, poultry farms, and diagnostic laboratories. In 2023, the veterinary hospitals & clinics segment was valued at USD 323.8 million, driven by the growing prevalence of poultry diseases and the demand for specialized diagnostic services that ensure accurate disease detection. In the U.S., valued at USD 257.8 million in 2023, the poultry diagnostics market is expected to reach USD 616.8 million by 2032

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing poultry consumption
    • 3.2.1.2 Growing awareness of poultry health
    • 3.2.1.3 Rising incidence of zoonotic diseases
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Limited access to advanced technologies in developing regions
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Pricing analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Products
  • 5.2.1 Kits & reagents
  • 5.2.2 Equipment & instruments
• 5.3 Services
  • 5.3.1 Clinical chemistry
  • 5.3.2 Molecular diagnostics
  • 5.3.3 Serology
  • 5.3.4 Bacteriology
  • 5.3.5 Virology
  • 5.3.6 Parasitology
  • 5.3.7 Other services

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 ELISA tests
• 6.3 PCR test
• 6.4 Other technologies

Chapter 7 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Avian influenza
• 7.3 Avian salmonellosis
• 7.4 Newcastle disease
• 7.5 Avian mycoplasmosis
• 7.6 Infectious bronchitis
• 7.7 Infectious bursal disease
• 7.8 Avian pasteurellosis
• 7.9 Avian encephalomyelitis
• 7.10 Avian reovirus
• 7.11 Chicken anemia
• 7.12 Other diseases

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals & clinics
• 8.3 Poultry farms
• 8.4 Diagnostic laboratories

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Affinitech
• 10.2 Agrobiotek Internacional
• 10.3 Agrolabo
• 10.4 Antech Diagnostics
• 10.5 BIOMERIEUX
• 10.6 Boehringer Ingelheim
• 10.7 Embark Veterinary
• 10.8 FUJIFILM Corporation
• 10.9 GD Animal Health
• 10.10 IDEXX Laboratories
• 10.11 IDvet
• 10.12 Innovative Diagnostics
• 10.13 Megacor Diagnostik
• 10.14 Thermo Fisher Scientific
• 10.15 Zoetis